Drug Trial Radar · NCT05831449
CPL-01 in the Management of Postoperative Pain After Bunionectomy
Last checked: Nov 19, 2026Latest source record: Apr 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
616
Actual
Start
May 22, 2023
Primary completion
Sep 25, 2025
Study completion Oct 6, 2025
Sponsor
- Lead sponsor
- Cali Pharmaceuticals LLCIndustry
- Sponsor type
- Industry
- First posted
- Apr 26, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Subjects receive study drug during bunionectomy and are followed for pain and opioid use, with the hypothesis that those who receive CPL-01 will have less pain and less opioid use than either control arm.
Conditions
- Bunion
- Post-operative Pain
Interventions
Local anesthetic injection of CPL-01Drug
Local anesthetic injection (CPL-01)
Naropin, 0.5% Injectable SolutionDrug
Local anesthetic injection (positive control \[Naropin\])
PlaceboDrug
Local anesthetic injection (negative control \[saline placebo\])
Morphine rescue medicationDrug
Rescue opioid (IV morphine) allowed if requested
Acetaminophen rescue medicationDrug
Rescue non-opioid (oral acetaminophen) allowed if requested
Oxycodone rescue medicationDrug
Rescue opioid (PO oxycodone) allowed if requested
BunionectomyProcedure
Operative bunion repair
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cumulative Pain ScoreTime frame: 72 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Todd Bertoch
Salt Lake City, Utah
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.